Concepedia

Daniel C. Maneval

DC

Statistics

Publications

50

Citations

3.9K

H-Index

29

Active since

1988

Affiliations

Halozyme Therapeutics (United States)(Current)

Slovenska Industrija Jekla (Slovenia)

The University of Texas MD Anderson Cancer Center

Centre Antoine Lacassagne

St. Jude Children's Research Hospital

Daniel C. Maneval is an author at Halozyme Therapeutics (United States) specializing in medicine, cell biology, and cancer research.

ORCID

Top concepts

Publications per year

1988–2023

50

Publications

50

Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer

Michael A. Jacobetz, Derek Chan, Tashinga E. Bapiro et al. · Gut · 2012 · 1.1K citations · Full text

Development and Characterization of Recombinant Adenoviruses Encoding Human p53 for Gene Therapy of Cancer

Ken N. Wills, Daniel C. Maneval, Patricia Menzel et al. · Human Gene Therapy · 1994 · 235 citations

, , +13

P53 tumor suppressor gene therapy for cancer.

Loretta L. Nielsen, Daniel C. Maneval · PubMed · 1998 · 218 citations

Successful Adenovirus-Mediated Wild-Type <i>p53</i> Gene Transfer in Patients With Bladder Cancer by Intravesical Vector Instillation

Jürgen Kuball, Shu Fen Wen, Derek Atkins et al. · Journal of Clinical Oncology · 2002 · 123 citations

Phase I Trial of Intravesical Recombinant Adenovirus Mediated Interferon-α2b Formulated in Syn3 for Bacillus Calmette-Guérin Failures in Nonmuscle Invasive Bladder Cancer

Colin P. Dinney, Mark B. Fisher, Neema Navai et al. · The Journal of Urology · 2013 · 120 citations · Full text

Rows per page

1–5 of 50